Archer Daniels Midland <ADM.N>: Morgan Stanley raises target price to $79.00 from $60.00
ADM•Related News
Journey Medical to report Q2 2026 results, host conference call
DERM•
Intelligent Bio Solutions completes usability study for FDA filing of codeine fingerprint drug test
INBS•
NNN REIT Q2 EPS USD 0.52
NNN•
Music giants’ AI bets fail to hit the right notes
SPOT•
Summit Therapeutics Initiates Global Phase II/III Harmoni-Gu1 Trial Of Ivonescimab In Bladder Cancer
SMMT•